ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

J. Torres; S. Bonovas; G. Doherty; T. Kucharzik; J.P. Gisbert; T. Raine; M. Adamina; A. Armuzzi; O. Bachmann; P. Bager; L. Biancone; B. Bokemeyer; P. Bossuyt; J. Burisch; P. Collins; A. El-Hussuna; P. Ellul; C. Frei-Lanter; F. Furfaro; C. Gingert; P. Gionchetti; F. Gomollon; M. Gonzalez-Lorenzo; H. Gordon; T. Hlavaty; P. Juillerat; K. Katsanos; U. Kopylov; E. Krustins; T. Lytras; C. Maaser; F. Magro; J.K. Marshall; P. Myrelid; G. Pellino; I. Rosa; J. Sabino; E. Savarino; A. Spinelli; L. Stassen; M. Uzzan; S. Vavricka; B. Verstockt; J. Warusavitarne; O. Zmora; G. Fiorino; European Crohn’s Colitis Organisation (ECCO)

doi:10.1093/ecco-jcc/jjz180

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

J. Torres
, S. Bonovas
, G. Doherty
, T. Kucharzik
, J.P. Gisbert
, T. Raine
, M. Adamina
, A. Armuzzi
, O. Bachmann
, P. Bager
, L. Biancone
, B. Bokemeyer
, P. Bossuyt
, J. Burisch
, P. Collins
, A. El-Hussuna
, P. Ellul
, C. Frei-Lanter
, F. Furfaro
, C. Gingert

P. Gionchetti, F. Gomollon, M. Gonzalez-Lorenzo, H. Gordon, T. Hlavaty, P. Juillerat, K. Katsanos, U. Kopylov, E. Krustins, T. Lytras, C. Maaser, F. Magro, J.K. Marshall, P. Myrelid, G. Pellino, I. Rosa, J. Sabino, E. Savarino, A. Spinelli, L. Stassen, M. Uzzan, S. Vavricka, B. Verstockt, J. Warusavitarne, O. Zmora, G. Fiorino^*, European Crohn’s Colitis Organisation (ECCO)

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

860 Downloads (Pure)

Original language	English
Pages (from-to)	4-22
Number of pages	19
Journal	Journal of Crohn's & Colitis
Volume	14
Issue number	1
DOIs	https://doi.org/10.1093/ecco-jcc/jjz180
Publication status	Published - 1 Jan 2020

Keywords

anti-tnf discontinuation
certolizumab pegol
double-blind trial
evidence-based consensus
inflammatory-bowel-disease
long-term
maintenance therapy
metaanalysis comparative efficacy
necrosis factor therapy
network metaanalysis
LONG-TERM
METAANALYSIS COMPARATIVE EFFICACY
CERTOLIZUMAB PEGOL
ANTI-TNF DISCONTINUATION
MAINTENANCE THERAPY
NETWORK METAANALYSIS
INFLAMMATORY-BOWEL-DISEASE
EVIDENCE-BASED CONSENSUS
DOUBLE-BLIND TRIAL
NECROSIS FACTOR THERAPY

Access to Document

10.1093/ecco-jcc/jjz180

Full text Final published version, 392 KBLicence: Taverne

Cite this

Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., El-Hussuna, A., Ellul, P., Frei-Lanter, C., Furfaro, F., ... European Crohn’s Colitis Organisation (ECCO) (2020). ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. Journal of Crohn's & Colitis, 14(1), 4-22. https://doi.org/10.1093/ecco-jcc/jjz180

@article{ff96799e7081408eb37bcb7cf498810f,

title = "ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment",

keywords = "anti-tnf discontinuation, certolizumab pegol, double-blind trial, evidence-based consensus, inflammatory-bowel-disease, long-term, maintenance therapy, metaanalysis comparative efficacy, necrosis factor therapy, network metaanalysis, LONG-TERM, METAANALYSIS COMPARATIVE EFFICACY, CERTOLIZUMAB PEGOL, ANTI-TNF DISCONTINUATION, MAINTENANCE THERAPY, NETWORK METAANALYSIS, INFLAMMATORY-BOWEL-DISEASE, EVIDENCE-BASED CONSENSUS, DOUBLE-BLIND TRIAL, NECROSIS FACTOR THERAPY",

author = "J. Torres and S. Bonovas and G. Doherty and T. Kucharzik and J.P. Gisbert and T. Raine and M. Adamina and A. Armuzzi and O. Bachmann and P. Bager and L. Biancone and B. Bokemeyer and P. Bossuyt and J. Burisch and P. Collins and A. El-Hussuna and P. Ellul and C. Frei-Lanter and F. Furfaro and C. Gingert and P. Gionchetti and F. Gomollon and M. Gonzalez-Lorenzo and H. Gordon and T. Hlavaty and P. Juillerat and K. Katsanos and U. Kopylov and E. Krustins and T. Lytras and C. Maaser and F. Magro and J.K. Marshall and P. Myrelid and G. Pellino and I. Rosa and J. Sabino and E. Savarino and A. Spinelli and L. Stassen and M. Uzzan and S. Vavricka and B. Verstockt and J. Warusavitarne and O. Zmora and G. Fiorino and \{European Crohn{\textquoteright}s Colitis Organisation (ECCO)\}",

note = "Funding Information: This project was initiated, funded, and supported by the European Crohn's and Colitis Organisation. Funding Information: This project was initiated, funded, and supported by the European Crohn{\textquoteright}s and Colitis Organisation.",

year = "2020",

month = jan,

day = "1",

doi = "10.1093/ecco-jcc/jjz180",

language = "English",

volume = "14",

pages = "4--22",

journal = "Journal of Crohn's \& Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "1",

}

Torres, J, Bonovas, S, Doherty, G, Kucharzik, T, Gisbert, JP, Raine, T, Adamina, M, Armuzzi, A, Bachmann, O, Bager, P, Biancone, L, Bokemeyer, B, Bossuyt, P, Burisch, J, Collins, P, El-Hussuna, A, Ellul, P, Frei-Lanter, C, Furfaro, F, Gingert, C, Gionchetti, P, Gomollon, F, Gonzalez-Lorenzo, M, Gordon, H, Hlavaty, T, Juillerat, P, Katsanos, K, Kopylov, U, Krustins, E, Lytras, T, Maaser, C, Magro, F, Marshall, JK, Myrelid, P, Pellino, G, Rosa, I, Sabino, J, Savarino, E, Spinelli, A, Stassen, L, Uzzan, M, Vavricka, S, Verstockt, B, Warusavitarne, J, Zmora, O, Fiorino, G & European Crohn’s Colitis Organisation (ECCO) 2020, 'ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment', Journal of Crohn's & Colitis, vol. 14, no. 1, pp. 4-22. https://doi.org/10.1093/ecco-jcc/jjz180

TY - JOUR

T1 - ECCO Guidelines on Therapeutics in Crohn's Disease

T2 - Medical Treatment

AU - Torres, J.

AU - Bonovas, S.

AU - Doherty, G.

AU - Kucharzik, T.

AU - Gisbert, J.P.

AU - Raine, T.

AU - Adamina, M.

AU - Armuzzi, A.

AU - Bachmann, O.

AU - Bager, P.

AU - Biancone, L.

AU - Bokemeyer, B.

AU - Bossuyt, P.

AU - Burisch, J.

AU - Collins, P.

AU - El-Hussuna, A.

AU - Ellul, P.

AU - Frei-Lanter, C.

AU - Furfaro, F.

AU - Gingert, C.

AU - Gionchetti, P.

AU - Gomollon, F.

AU - Gonzalez-Lorenzo, M.

AU - Gordon, H.

AU - Hlavaty, T.

AU - Juillerat, P.

AU - Katsanos, K.

AU - Kopylov, U.

AU - Krustins, E.

AU - Lytras, T.

AU - Maaser, C.

AU - Magro, F.

AU - Marshall, J.K.

AU - Myrelid, P.

AU - Pellino, G.

AU - Rosa, I.

AU - Sabino, J.

AU - Savarino, E.

AU - Spinelli, A.

AU - Stassen, L.

AU - Uzzan, M.

AU - Vavricka, S.

AU - Verstockt, B.

AU - Warusavitarne, J.

AU - Zmora, O.

AU - Fiorino, G.

AU - European Crohn’s Colitis Organisation (ECCO)

N1 - Funding Information: This project was initiated, funded, and supported by the European Crohn's and Colitis Organisation. Funding Information: This project was initiated, funded, and supported by the European Crohn’s and Colitis Organisation.

PY - 2020/1/1

Y1 - 2020/1/1

KW - anti-tnf discontinuation

KW - certolizumab pegol

KW - double-blind trial

KW - evidence-based consensus

KW - inflammatory-bowel-disease

KW - long-term

KW - maintenance therapy

KW - metaanalysis comparative efficacy

KW - necrosis factor therapy

KW - network metaanalysis

KW - LONG-TERM

KW - METAANALYSIS COMPARATIVE EFFICACY

KW - CERTOLIZUMAB PEGOL

KW - ANTI-TNF DISCONTINUATION

KW - MAINTENANCE THERAPY

KW - NETWORK METAANALYSIS

KW - INFLAMMATORY-BOWEL-DISEASE

KW - EVIDENCE-BASED CONSENSUS

KW - DOUBLE-BLIND TRIAL

KW - NECROSIS FACTOR THERAPY

U2 - 10.1093/ecco-jcc/jjz180

DO - 10.1093/ecco-jcc/jjz180

M3 - Article

C2 - 31711158

SN - 1873-9946

VL - 14

SP - 4

EP - 22

JO - Journal of Crohn's & Colitis

JF - Journal of Crohn's & Colitis

IS - 1

ER -